HD Rx of Hyperammonemia (Gregory et al, Vol. 5,abst. 55P

Download Report

Transcript HD Rx of Hyperammonemia (Gregory et al, Vol. 5,abst. 55P

PCRRT for Metabolic
Disease
Timothy E. Bunchman
Professor Pediatrics
Signs and Symptoms of
Hyperammonemia
Initially healthy appearing neonate with
decompensation after several days
Often seen after institution of protein
feedings
Lethargy
Poor feeding
Vomiting
Hypotonia
bunchman
Signs and Symptoms of
Hyperammonemia
Respiratory distress, tachypnea, apnea
Irritability
Seizure activity
Neurologic deterioration leading to coma
Death
bunchman
Long Term Effects of
Neonatal Ammonemia
Demonstrated correlation between
prolonged neonatal hyperammonemic
coma and brain damage with impaired
intellectual functioning
Did not demonstrate correlation between
peak ammonia level and level of
intellectual impairment
[Msall et al. NEJM, 1984]
bunchman
Major Causes of
Hyperammonemia
Urea cycle defects
Organic acidemias
Transient hyperammonemia of the
newborn
Severe asphyxia - increased protein
breakdown during hypoxic stress plus liver
damage due to ischemia
Liver failure - due to multiple causes
bunchman
particularly infection
Flow Diagram to Evaluate
Hyperammonemia
acidosis
Increased
ammonia
Lactate/pyruvate
No
acidosis
bunchman
Urine for
organic acids
Plasma amino
acids
Flow Diagram to Evaluate
Hyperammonemia
Sig
incr
Plasma amino
acids
citrulline
citrullinemia
Nl.
Nl. Or sl.
increased
ASA
Incr.
low
urine
Orotic acid
bunchman
THN
Low or
absent
Incr.
ASA
CPS
OTC
Treatment of Ammonemia
Prior to Further Diagnosis
Prevent further catabolism by providing
adequate calories, fluids and electrolytes
Minimize protein intake
Provide alternate pathways for ammonia
removal
May require exchange transfusion,
peritoneal dialysis or hemodialysis for
ammonia removal
bunchman
Alternate Pathways for
Removal of Ammonia
Sodium benzoate
SODIUM BENZOATE
HIPPURATE
+ GLYCINE
Cleared by the kidney at 5X the GFR
Each mole of benzoate removes one
mole of ammonia as glycine
bunchman
Alternate Pathways for
Removal of Ammonia
Sodium phenylacetate
PHENYL- + GLUTAMINE
ACETATE
PHENYlAC
ETYLGLUTAMIN
E
Easily excreted in the urine
One mole of phenylacetate removes 2
moles of ammonia as glutamine
bunchman
Alternate Pathways for
Removal of Ammonia
Arginine supplementation provides the
urea cycle with ornithine and nacetylglutamate
Abbreviated version of the urea cycle
continues
not recommended for use in arginase
deficiency or organic acidemias
bunchman
But what do I do when the
drugs don’t work?
bunchman
You call your friendly
dialysis folks
bunchman
Mode of RRT
PD
nope
Hemodialysis
looks like a good place to start
Hemofiltration
a great way to go home at night
bunchman
micromoles/l
NH4
HD Rx of ammonemia
(Gregory et al, Vol. 5,abst. 55P,1994: )
2000
1800
1600
1400
1200
1000
800
600
400
200
0
NH4 rebound with reinstitution of HD
0
bunchman
1
2
3
4
5
6 10 11 12 13 17 18 19 20
Time
(Hrs)
HD to CRRT
(prevention of the rebound)
1200
micromoles/L
NH4
1000
800
Transition from HD to CVVHD
600
400
200
0
0
bunchman
1
2
3
4
5
Time
(Hrs)
10
11
17
Local experience
(McBryde et al, JASN 2000)
18 children underwent 20 therapies of
RRT due to in-born error of metabolism
mean age 56 + 7.9 mos
mean weight 15 + 3.7 kg (smallest 1.2
kg)
mean duration of therapy 6.1 + 1.3 days
bunchman
Local experience
(McBryde et al, JASN 2000)
Modalities used
HD only-9
time on HD 2.2 + 0.9 days
HF only-3
time on HF 6.3 + 2.9 days
HD followed by HF-8
time on HD + HF 10.25 + 1.8 days
bunchman
Local experience
(McBryde et al, JASN 2000)
Outcome
12/18 patients survived
2/12 continued to be medication and RRT
dependent
bunchman
But what do I do when the
drugs and RRT doesn’t
work?
bunchman
You call your friendly liver
transplant folks
bunchman
CVVHD for NH4 Bridge to
Hepatic Transplantation
800
700
micromoles/L
NH4
600
Successful Liver
Transplantation
500
400
300
200
100
0
1
bunchman
2
4
6
8
Time
(days)
10
12
14
16
Considerations of PCRRT
for metabolic disease
Dialysis Bath
“metabolic cocktail” clearance
nutritional needs with the balance of
restricted protein intake and amino acid
loss via HF
bunchman
Hemodialysis Bath
Considerations
Electrolyte
Na (meq/l)
Cl (meq/l)
Glucose (mg/dl)
Ca (mg/dl)
MG (meq/l)
HCO3 (meq/l)
K (meq/l)
Phos (mg/dl)
bunchman
ARF
140
96
200
3.5
1
40
0-3
0
Metabolic
140
96
200
3.5
1
40
4-5
4-5 (add to B jug)
Metabolic Cocktail drug
clearance
Drug clearance related
small molecular weight
minimal protein binding
volume of distribution
Phenylacetate, Benzoate, Arginine all will
be cleared
? Re bolus?
bunchman
Comparison of Total Amino
Acid losses: CVVH vs
CVVHD
(Maxvold et al, Crit Care Med April 2000)
Amino Acid Losses
(g/day/1.73 m2)
16
14
12
10
8
6
4
2
0
CVVH
bunchman
CVVHD
Conclusion
Hyperammonemia is a medical emergency
When medical management does not
work consider RRT early
HD should be used initially with HF in
tandem
Liver transplant should be considered if
medical and RRT management is not
successful
bunchman